Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved PREVNAR 20™ (Pneumococcal...
A leading group of New South Wales (NSW) experts, including from the University of Sydney, have received funding from th...
The Therapeutic Goods Administration (TGA) in Australia has implemented arrangements to facilitate the communication of ...
World leaders joined forces on 2 June at the “One World Protected” - Gavi COVAX Advance Market Commitme...
Gavi, the Vaccine Alliance, welcomes the announcement by the United States Government of its strategy for glob...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Bahrain’s Mumtalakat Holding Comp...
The International Vaccine Institute (IVI) in South Korea has announced that the Bill & Melinda Gates Foundation has ...
Canadian firm Providence Therapeutics Holdings Inc. and India's Biological E have announced the execution of a term shee...
The World Health Organisation (WHO) has validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving ...
Reduced levels of a metabolic hormone known as leptin, largely produced by fat tissue, is linked to poor vaccine antibod...
CEPI, the Coalition for Epidemic Preparedness Innovations, and SK bioscience have announced an expanded partnership to d...
The Health Sciences Authority (HSA) in Singapore has approved the new storage condition for the Pfizer-BioNTech COVID-19...
CanSino Biologics Inc has announced that its recombinant novel coronavirus vaccine, (Adenovirus Type 5 Vector) (‘A...
Novavax, Inc., a US-based biotechnology company developing next-generation vaccines for serious infectious diseases, has...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading v...
Last month was World Immunization Week and never has it been a more pertinent milestone. It has been 13 months since the...
The Health Sciences Authority (HSA) at Singapore has extended the authorisation of Pfizer-BioNTech COVID-19 vaccine for ...
A single-dose vaccine that targets new COVID-19 variants has been awarded funding to fast-track testing in human trials....
